Natco Pharma

  • Cancer drug made cheaper, patients to benefit 13-03-2012 07:02 PM

    Mumbai: The Indian Patent Office has given the Hyderabad-based Natco Pharma Limited the go-ahead in the form of a compulsory license to legally make and sell a low-cost generic version of German company Bayer's anti-cancer drug, Nexavar. The Controller of Patents PH Kurian, in a 62-page ruling, observed that with...
  • Industry split over nod to Natco to sell Bayer's drug 13-03-2012 04:56 PM

    New Delhi: India's decision to allow Natco Pharma to sell Bayer's patented cancer drug Nexavar has divided the pharmaceutical industry with domestic firms welcoming it while multinationals said 'arbitrarily' using of compulsory licenses will undermine innovation in the sector. Disappointed with the development, Bayer said it is evaluating options for...
  • Rs 2.84-lakh cancer drug to cost Rs 8,880 13-03-2012 11:31 AM

    New Delhi: Bringing huge relief to cancer and kidney patients in India, the government on Monday allowed Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by its patent-holder and German multinational Bayer Corporation under Section 84 of the Indian...